UNAIDS Urges Greater Access for Gilead’s ...

By Rene Pretorius

October 16, 2024

The press statement from UNAIDS, dated October 2, 2024, highlights Gilead's announcement regarding the breakthrough HIV medicine lenacapavir, offering sev...
Soaring Drug Prices in Europe: A Strain on Health Systems and Industry
The Readiness of Biosimilars in Multiple Sclerosis Treatment
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...
Addressing the Challenges of Value Attribution in Combination Therapies
Global Disparities in Pneumonia Vaccine Access
New Anti-Obesity Medications Should Be Considered Preventive Health Care
Understanding the Cost and Funding of Gene Therapies
The Economic Burden of Liver Transplantation for Hepatitis B in Italy
Access to Essential Medicines for Rheumatic Diseases in Children
Biosimilars in Juvenile Arthritis Management: Connecting the Treatment Continuum
The Role of Pull Incentives in Addressing Antimicrobial Resistance
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...